Dow Up 0.03% Nasdaq Up 0.37%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
6.23 Up 0.07(1.21%) 12:55PM EDT - Nasdaq Real Time Price
Prev Close:6.16
Open:6.16
Bid:6.24 x 1200
Ask:6.25 x 4200
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:6.16 - 6.36
52wk Range:2.15 - 23.00
Volume:2,088,384
Avg Vol (3m):8,088,250
Market Cap:1.17B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 1.21%1.17B
NVSUp 0.14%218.02B
PFEUp 0.12%186.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback